Clinical trials for a laser treatment targeting this common eye disease will begin in Finland next spring, and researchers hope it could become available to patients within three years. About one in three people over the age of 80 are affected by age-related macular degeneration (AMD), and roughly 20 million Americans aged 40 and older […]
Full article can be found at: https://scitechdaily.com/groundbreaking-new-treatment-is-the-first-to-halt-this-common-eye-disease/
